Robert T. Chen

Also affiliated with National Patient Safety Foundation

Social SciencesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services”.

Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services

Clinical Infectious Diseases(2022)10.1093/cid/ciac407

N/A

0DataRank · unranked

22 citations

Robert T. Chen, Ofer Levy, Al Ozonoff, Bruce Carleton, Nigel W. Crawford +6 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

Vaccine(2022)10.1016/j.vaccine.2022.06.005

N/A

0DataRank · unranked

8 citations

Walter L. Straus, P. White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo +5 more

System and facility readiness assessment for conducting active surveillance of adverse events following immunization in Addis Ababa, Ethiopia

International Health(2023)10.1093/inthealth/ihac085

N/A

0DataRank · unranked

9 citations

Getnet Yimer, Leuel Lisanework, Robert T. Chen, Wan‐Ting Huang, Shuhua Wang +3 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spike protein vaccine with Matrix-M adjuvant to prevent disease caused by SARS-CoV-2 viruses

Vaccine(2023)10.1016/j.vaccine.2023.07.040

N/A

0DataRank · unranked

3 citations

Kinjal S. Patel, Katherine R. Smith, Robert Walker, Chengbin Wang, Ann M. Greene +5 more

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever

Vaccine(2025)10.1016/j.vaccine.2025.127137

N/A

0DataRank · unranked

0 citations

Melissa Wynn, L. J. Charles, Stefan Hamm, Demetrius Matassov, Cheryl Gerardi +4 more